Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE)

Peter Monteleone, Ryan Ahern, Subhash Banerjee, Kush R. Desai, Daniella Kadian-Dodov, Emily Webber, Sally Omidvar, Patrick Troy, Sahil A. Parikh

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Background: Advanced therapies are increasingly utilized to treat pulmonary embolism (PE). A unique data platform allows access to electronic health record data for comparison of the safety of PE therapies. Methods: All data from Truveta (Truveta, Inc) were analyzed (16 systems, 83,612,413 patients, 535,567 with PE). All patients treated with ultrasound-assisted catheter-directed thrombolysis (USCDT) (Boston Scientific) or mechanical thrombectomy (MT) (Inari Medical) for PE were identified. The primary analysis was based on index procedures performed from January 2009 to May 2023, and contemporary analysis on those performed from January 2018 to May 2023. Bleeding was assessed via direct laboratory analysis and transfusion administration documentation. International Society for Thrombosis and Hemostasis (ISTH) and Bleeding Academic Research Consortium (BARC) 3b definitions were recreated. Multiple logistic regression analysis of major bleeding was performed. In-hospital death and median length of stay were measured. Results: For the primary analysis, 2259 patients (N = 1577 USCDT, N = 682 MT) and for the contemporary analysis 1798 patients (N = 1137 USCDT, N = 661 MT) met the criteria. Incidence of hemoglobin reduction (>2 and >5 g/dL) and transfusions received were significantly higher among MT-treated patients in both analyses, as was ISTH and BARC 3b major bleeding (primary: ISTH MT 17.3% vs USCDT 12.4% P =.002; BARC 3b MT 15.4% vs USCDT 11.8% P =.019) (contemporary: ISTH MT 17.2% vs USCDT 11.0% P =.0002; BARC 3b MT 15.4% vs USCDT 10.6% P =.002). Regression analysis demonstrated that MT is associated with major bleeding. Median length of stay, all-cause 30-day readmission and in-hospital mortality were similar between groups. Intracranial hemorrhage was more common with MT. Conclusions: Major bleeding derived from direct laboratory and transfusion data occurred more frequently with MT vs USCDT. Intracranial hemorrhage was more common among MT-treated patients. In the absence of randomized data, these results provide guidance regarding the bleeding risk and safety of strategies for advanced PE therapy.

Original languageEnglish
Article number101192
JournalJournal of the Society for Cardiovascular Angiography and Interventions
Volume3
Issue number1
DOIs
StatePublished - Jan 2024

Keywords

  • bleeding
  • pulmonary embolism
  • thrombectomy
  • thrombolysis

Fingerprint

Dive into the research topics of 'Modern Treatment of Pulmonary Embolism (USCDT vs MT): Results From a Real-World, Big Data Analysis (REAL-PE)'. Together they form a unique fingerprint.

Cite this